Menu
Back to Journals » OncoTargets and Therapy » Volume 4
Review
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,737 | Dovepress* | 10,843+ | 3,306 | 14,149 | |
| PubMed Central* | 3,894 | 2,799 | 6,693 | ||
| Totals | 14,737 | 6,105 | 20,842 | ||
|
*Since 30 May 2011 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar